BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38702792)

  • 21. cRGD-functionalized nanoparticles for combination therapy of anti-endothelium dependent vessels and anti-vasculogenic mimicry to inhibit the proliferation of ovarian cancer.
    Wang Y; Tong L; Wang J; Luo J; Tang J; Zhong L; Xiao Q; Niu W; Li J; Zhu J; Chen H; Li X; Wang Y
    Acta Biomater; 2019 Aug; 94():495-504. PubMed ID: 31252171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytosolic TGM2 promotes malignant progression in gastric cancer by suppressing the TRIM21-mediated ubiquitination/degradation of STAT1 in a GTP binding-dependent modality.
    Zhang L; Li Q; Yang J; Xu P; Xuan Z; Xu J; Xu Z
    Cancer Commun (Lond); 2023 Jan; 43(1):123-149. PubMed ID: 36353796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRIM21 mediates ubiquitination of Snail and modulates epithelial to mesenchymal transition in breast cancer cells.
    Jin Y; Zhang Y; Li B; Zhang J; Dong Z; Hu X; Wan Y
    Int J Biol Macromol; 2019 Mar; 124():846-853. PubMed ID: 30502437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subpopulations of uPAR+ contribute to vasculogenic mimicry and metastasis in large cell lung cancer.
    Li Y; Sun B; Zhao X; Zhang D; Wang X; Zhu D; Yang Z; Qiu Z; Ban X
    Exp Mol Pathol; 2015 Apr; 98(2):136-44. PubMed ID: 25661888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.
    Aikins AR; Kim M; Raymundo B; Kim CW
    Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EDARADD promotes colon cancer progression by suppressing E3 ligase Trim21-mediated ubiquitination and degradation of Snail.
    Yang J; Liao Y; Wang B; Cui L; Yu X; Wu F; Zhang Y; Liu R; Yao Y
    Cancer Lett; 2023 Nov; 577():216427. PubMed ID: 37838280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of sema4D in vasculogenic mimicry formation in non-small cell lung cancer and the underlying mechanisms.
    Xia Y; Cai XY; Fan JQ; Zhang LL; Ren JH; Li ZY; Zhang RG; Zhu F; Wu G
    Int J Cancer; 2019 May; 144(9):2227-2238. PubMed ID: 30374974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Migration-inducing gene-7 independently predicts poor prognosis of human osteosarcoma and is associated with vasculogenic mimicry.
    Ren K; Zhang J; Gu X; Wu S; Shi X; Ni Y; Chen Y; Lu J; Gao Z; Wang C; Yao N
    Exp Cell Res; 2018 Aug; 369(1):80-89. PubMed ID: 29750896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of Aquaporin 1-Inhibition on Vasculogenic Mimicry in Malignant Mesothelioma.
    Pulford E; McEvoy J; Hocking A; Prabhakaran S; Griggs K; Klebe S
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29104239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 31. The deubiquitinase USP7 promotes HNSCC progression via deubiquitinating and stabilizing TAZ.
    Li J; Dai Y; Ge H; Guo S; Zhang W; Wang Y; Liu L; Cheng J; Jiang H
    Cell Death Dis; 2022 Aug; 13(8):677. PubMed ID: 35931679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo apatinib inhibits vasculogenic mimicry in melanoma MUM-2B cells.
    Liu ZJ; Zhou YJ; Ding RL; Xie F; Fu SZ; Wu JB; Yang LL; Wen QL
    PLoS One; 2018; 13(7):e0200845. PubMed ID: 30052652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis.
    Chen JJ; Ren YL; Shu CJ; Zhang Y; Chen MJ; Xu J; Li J; Li AP; Chen DY; He JD; Shu YQ; Zhou JW
    J Exp Clin Cancer Res; 2020 Jun; 39(1):118. PubMed ID: 32576271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Notch1 promotes vasculogenic mimicry in hepatocellular carcinoma by inducing EMT signaling.
    Jue C; Lin C; Zhisheng Z; Yayun Q; Feng J; Min Z; Haibo W; Youyang S; Hisamitsu T; Shintaro I; Shiyu G; Yanqing L
    Oncotarget; 2017 Jan; 8(2):2501-2513. PubMed ID: 27705934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes.
    Han H; Du L; Cao Z; Zhang B; Zhou Q
    Eur J Pharmacol; 2018 Jan; 818():593-603. PubMed ID: 29162433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TAZ promotes vasculogenic mimicry in gastric cancer through the upregulation of TEAD4.
    Zhang Y; Bai J; Cheng R; Zhang D; Qiu Z; Liu T; Che N; Dong X; Zhao N; Lin X; Liang X; Li F; Li Y; Sun B; Zhao X
    J Gastroenterol Hepatol; 2022 Apr; 37(4):714-726. PubMed ID: 35062042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. USP7 mediates TRAF4 deubiquitination to facilitate the malignant phenotype of ovarian cancer via the RSK4/PI3K/AKT axis.
    Wang Y; Luo X; Wu N; Liao Q; Wang J
    J Cancer Res Ther; 2023 Feb; 19(1):97-107. PubMed ID: 37006049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caveolin-1 promotes tumor cell proliferation and vasculogenic mimicry formation in human glioma.
    Chen W; Cheng X; Wang X; Hu W; Wang J; Liao C
    Braz J Med Biol Res; 2021; 54(10):e10653. PubMed ID: 34287575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ubiquitin-specific peptidase 7 (USP7) and USP10 mediate deubiquitination of human NHE3 regulating its expression and activity.
    Han Y; Yun CC
    FASEB J; 2020 Dec; 34(12):16476-16488. PubMed ID: 33095475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
    Wang HF; Wang SS; Zheng M; Dai LL; Wang K; Gao XL; Cao MX; Yu XH; Pang X; Zhang M; Wu JB; Wu JS; Yang X; Tang YJ; Chen Y; Tang YL; Liang XH
    Cell Prolif; 2019 May; 52(3):e12600. PubMed ID: 30945361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.